NCT03803644View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of Single Ascending Doses of CC-92480 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

December 21, 2018

Primary Completion Date

May 28, 2019

Study Completion Date

May 28, 2019

Conditions
Healthy Volunteer
Interventions
DRUG

CC-92480

Part 1 dose escalation

DRUG

CC-92480

CC-92480

Trial Locations (1)

32117

Covance-Daytona Beach, Daytona Beach

Sponsors

Lead Sponsor

Celgene
All Listed Sponsors
lead

Celgene

INDUSTRY

NCT03803644 - Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of Single Ascending Doses of CC-92480 in Healthy Subjects | Biotech Hunter | Biotech Hunter